Achim Leutz Selected Research

CCAAT-Enhancer-Binding Protein-beta

3/2010	Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases.
1/2010	C/EBPbetaDeltauORF mice--a genetic model for uORF-mediated translational control in mammals.
6/2009	Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB.
9/2005	A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas.
1/2004	Ras induces mediator complex exchange on C/EBP beta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Achim Leutz Research Topics

Disease

9	Neoplasms (Cancer) 01/2019 - 02/2002
6	Carcinogenesis 01/2021 - 01/2004
3	Leukemia 01/2021 - 06/2002
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2018
2	Bone Resorption 01/2012 - 06/2009
1	Vasculitis (Vasculitides) 01/2022
1	Glomerulonephritis 01/2022
1	Coinfection 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Polyps 01/2019
1	Stomach Neoplasms (Stomach Cancer) 12/2016
1	Lymphoma (Lymphomas) 09/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2014
1	Blast Crisis (Blast Phase) 10/2013
1	Osteoporosis 02/2012
1	Giant Cell Tumor of Bone 01/2012
1	Bone Diseases (Bone Disease) 03/2010
1	Infections 03/2010
1	Acute-Phase Reaction 01/2010
1	Atherosclerosis 08/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2006
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2005
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 02/2003

Drug/Important Bio-Agent (IBA)

7	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2003
5	CCAAT-Enhancer-Binding Protein-betaIBA 03/2010 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2002
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 02/2002
3	Protein Isoforms (Isoforms)IBA 01/2015 - 03/2010
3	Sirolimus (Rapamycin)FDA Link 01/2012 - 09/2005
2	CateninsIBA 01/2019 - 10/2013
2	CCAAT-Enhancer-Binding ProteinsIBA 01/2019 - 09/2014
2	CCAAT-Enhancer-Binding Protein-alphaIBA 05/2010 - 02/2004
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	ChromatinIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Terminator Codon (Termination Codon)IBA 01/2018
1	Differentiation AntigensIBA 12/2016
1	CytokinesIBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014
1	AntigensIBA 09/2014
1	Imatinib Mesylate (Gleevec)FDA Link 10/2013
1	A-factor (Streptomyces)IBA 02/2012
1	Platelet-Derived Growth FactorIBA 08/2007
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2007
1	Messenger RNA (mRNA)IBA 02/2006
1	ElementsIBA 01/2006
1	proto-oncogene protein Spi-1IBA 01/2006
1	NF-kappa B (NF-kB)IBA 09/2005
1	Everolimus FDA Link 09/2005
1	Co-Repressor ProteinsIBA 02/2002

Therapy/Procedure

1	Therapeutics 10/2013
1	Hepatectomy 01/2010